IHH Healthcare Berhad (Q0F.SI): A Strong Contender in Singapore’s Healthcare Sector
As of December 12, 2025, IHH Healthcare Berhad (Q0F.SI) is making significant waves on the Singapore Exchange with its stock price rising to S$2.70, marking an increase of 2.66% for the day. This healthcare behemoth, with operations spanning Asia, Europe, and beyond, is capturing the attention of investors through both its vast footprint and strategic growth.
Fundamental Analysis
IHH Healthcare Berhad stands out with a market capitalization of S$23.42 billion. The stock is trading at a price-to-earnings ratio (P/E) of 33.13, indicating market anticipation of continued earnings growth despite a recent decline in net income growth (down 9.99%). The company boasts a robust revenue per share of S$2.83, aligning with its diversified services in medical care facilities across multiple regions.
Technical Indicators
The stock’s Relative Strength Index (RSI) of 61.46 suggests a neutral trend, but its Average Directional Index (ADX) at 34.13 indicates a strong underlying trend. The Moving Average Convergence Divergence (MACD) is at 0.02, which slightly trails its signal line, posing a potential for upward momentum. IHH’s current volatility is low, with an Average True Range (ATR) of 0.04.
Growth Trajectory and Sector Performance
IHH Healthcare has demonstrated resilience with a 3-month price appreciation of 22.86% and a year-to-date growth of 16.22%. The healthcare sector in Singapore, known for stability and slow, steady growth, provides a supportive backdrop. Despite a slight pullback in earnings growth, the company benefits from a strategic focus on expansion and technology integration, leveraging its large-scale operations.
Market Sentiment and Analyst Projections
Market sentiment around IHH Healthcare Berhad remains optimistic. Analysts, leveraging platforms like Meyka AI, forecast a 5-year price target nearing S$6.08, driven by anticipated technological enhancements and expanding service offerings. The current Dividend Yield is 1.21%, suggesting a solid return on investment for long-term shareholders.
Final Thoughts
Overall, IHH Healthcare Berhad continues to be a pivotal part of Singapore’s healthcare market. Its current stock performance on the Singapore Exchange reflects both investor confidence and the company’s capacity to navigate and lead within the medical care facilities industry. Stock prices can fluctuate based on market conditions, economic factors, and company-specific events.
FAQs
As of December 12, 2025, the stock price of IHH Healthcare Berhad (Q0F.SI) on the Singapore Exchange is S$2.70, reflecting a 2.66% increase on the day.
Key metrics include a P/E ratio of 33.13, market capitalization of S$23.42 billion, and an EPS of S$0.08. The company has a revenue per share of S$2.83.
Year-to-date, the stock has increased by 16.22%, showcasing strong performance relative to the healthcare sector average in Singapore, aided by strategic growth initiatives.
Analysts project a 5-year price target of approximately S$6.08, driven by technological advancements and expansion into new healthcare markets, as per insights from Meyka AI.
The healthcare sector in Singapore is known for its stability. With IHH Healthcare’s strategic growth in medical care facilities, the sector outlook remains positive, supported by global expansion and service diversification.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
